Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James Sapirstein currently holds 3,477 shares of ContraVir Pharmaceuticals, Inc. (CTRV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Sapirstein has been a net seller of CTRV stock. They have purchased $15.2K and sold $26.5K worth of shares.
James Sapirstein's most recent insider trade was on Sep 26, 2024, when they sold 3,318 shares at $0.00 per share.
James Sapirstein serves as Executive at ContraVir Pharmaceuticals, Inc. (CTRV). They have executed 28 insider transactions totaling $41.7K over their tenure at the company.
James Sapirstein holds the position of Executive at ContraVir Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
James Sapirstein has shown a selling trading pattern, with $15.2K in total purchases and $26.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James Sapirstein was on Nov 27, 2013, when they sold $63.8K worth of ALQA shares. This transaction involved 14,299 shares at $4.46 per share.
James Sapirstein currently owns 3,477 shares of ContraVir Pharmaceuticals, Inc. (CTRV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James Sapirstein's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James Sapirstein has 28 Form 4 filings on record as an insider at ContraVir Pharmaceuticals, Inc..
Set alerts for James Sapirstein and 40,000+ other insiders.